Thromboembolic risk in subcutaneous versus intravenous immunoglobulin therapy: a systematic review and narrative meta-synthesis

Clinical and Experimental Medicine · Published 2026-06-10 · DOI 10.1007/s10238-026-02207-2

Free full text

Authors (3)

Shihshuan Fang, Yu-Chieh Chen, Shenghan Chen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Fang, S., Chen, Y., Chen, S. (2026). Thromboembolic risk in subcutaneous versus intravenous immunoglobulin therapy: a systematic review and narrative meta-synthesis. Clinical and Experimental Medicine. https://doi.org/10.1007/s10238-026-02207-2

Related articles

• LRP8 drives cervical cancer lymph node metastasis by promoting epithelial-mesenchymal transition and VEGF-C secretion · Clinical and Experimental Medicine · 2026 · Same journal
• Global trends in the burden of inflammatory bowel disease from 1990 to 2021: socioeconomic and sex-specific disparities with exploratory mendelian randomization analyses · Clinical and Experimental Medicine · 2026 · Same journal
• Extranodal involvement defines distinct immune-molecular phenotypes and clinical outcomes in diffuse large b-cell lymphoma · Clinical and Experimental Medicine · 2026 · Same journal
• Pan-cancer analysis identifies KANSL2 as a cell-cycle–associated regulator of tumor progression and immunity in liver hepatocellular carcinoma · Clinical and Experimental Medicine · 2026 · Same journal
• Serum TIMP-1 shows a potential association with metastatic disease in patients with pancreatic cancer: a pilot analysis without a healthy control cohort · Clinical and Experimental Medicine · 2026 · Same journal
• Integrated bioinformatic evaluation unveils a cellular senescence gene signature as a poor prognostic factor in hepatocellular carcinoma · Clinical and Experimental Medicine · 2026 · Same journal
• Population-specific association and risk discrimination utility of the cardiometabolic index for prevalent hypertension–diabetes comorbidity: insights from CHARLS and NHANES · Clinical and Experimental Medicine · 2026 · Same journal
• Beyond polarization: a receptor-centered framework for macrophage function and therapy in skin diseases · Clinical and Experimental Medicine · 2026 · Same journal
• Dissecting PCD-driven molecular landscapes in AML: a multi-omic framework for prognostication and therapeutic targeting · Clinical and Experimental Medicine · 2026 · Same journal
• Neuropeptide Y promotes myocardial fibrosis post myocardial infarction reperfusion through Neuropeptide Y receptor type 1 · Clinical and Experimental Medicine · 2026 · Same journal